| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.815 | 0.005 | 0.815 | Antiobesity | 0.591 0.022 CID_6453821 | ||
| 0.627 | 0.005 | 0.627 | GABA C receptor rho-3 antagonist | 0.539 0.017 CID_6453821 | ||
| 0.562 | 0.019 | 0.562 | 5 Hydroxytryptamine release stimulant | 0.376 0.051 CID_6453821 | ||
| 0.543 | 0.021 | 0.543 | 5 Hydroxytryptamine release inhibitor | 0.442 0.055 CID_6453821 | ||
| 0.525 | 0.029 | 0.525 | Aldehyde oxidase inhibitor | 0.441 0.041 CID_6453821 | ||
| 0.52 | 0.044 | 0.52 | Analgesic | 0.367 0.099 CID_6453821 | ||
| 0.494 | 0.034 | 0.494 | Cholesterol antagonist | 0.367 0.058 CID_6453821 | ||
| 0.43 | 0.01 | 0.43 | 5 Hydroxytryptamine uptake stimulant | 0.386 0.017 CID_6453821 | ||
| 0.416 | 0.005 | 0.416 | Glutamate receptor antagonist | 0.227 0.019 CID_6453821 | ||
| 0.415 | 0.035 | 0.415 | Aryl hydrocarbon receptor agonist | 0.227 0.089 CID_6453821 | ||
| 0.392 | 0.027 | 0.392 | Calcium channel activator | 0.335 0.06 CID_6453821 | ||
| 0.363 | 0.003 | 0.363 | Glutamate release inhibitor | 0.31 0.003 CID_6453821 | ||
| 0.381 | 0.03 | 0.381 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.426 | 0.079 | 0.426 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.311 0.199 CID_6453821 | ||
| 0.422 | 0.079 | 0.422 | Cyclophilin D inhibitor | 0.397 0.093 CID_6453821 | ||
| 0.343 | 0.004 | 0.343 | Cannabinoid receptor antagonist | 0.122 0.021 CID_6453821 | ||
| 0.339 | 0.007 | 0.479 | Cystathionine beta-synthase inhibitor | 0.479 0.004 CID_6453821 | CID_6453821 | |
| 0.336 | 0.006 | 0.34 | Succinate dehydrogenase inhibitor | 0.34 0.006 CID_6453821 | CID_6453821 | |
| 0.324 | 0.004 | 0.324 | Cannabinoid CB1 receptor antagonist | 0.097 0.017 CID_6453821 | ||
| 0.374 | 0.055 | 0.374 | Streptokinase A inhibitor | 0.299 0.079 CID_6453821 | ||
| 0.347 | 0.03 | 0.347 | Anticonvulsant | 0.152 0.126 CID_6453821 | ||
| 0.319 | 0.003 | 0.319 | Aryl hydrocarbon receptor antagonist | 0.139 0.005 CID_6453821 | ||
| 0.316 | 0.003 | 0.316 | Lanosterol 14 alpha demethylase inhibitor | 0.192 0.005 CID_6453821 | ||
| 0.31 | 0.004 | 0.31 | Potassium channel large-conductance Ca-activated activator | 0.22 0.005 CID_6453821 | ||
| 0.308 | 0.006 | 0.308 | Aminoacyl-tRNA synthetase inhibitor | 0.237 0.009 CID_6453821 | ||
| 0.305 | 0.006 | 0.305 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.233 0.011 CID_6453821 | ||
| 0.321 | 0.028 | 0.321 | RNA-directed DNA polymerase inhibitor | 0.291 0.033 CID_6453821 | ||
| 0.296 | 0.005 | 0.296 | Potassium channel (Ca-activated) activator | 0.273 0.006 CID_6453821 | ||
| 0.309 | 0.031 | 0.309 | Anesthetic general | 0.226 0.061 CID_6453821 | ||
| 0.314 | 0.039 | 0.314 | Psychostimulant | 0.175 0.096 CID_6453821 | ||
| 0.279 | 0.009 | 0.279 | Chemokine receptor antagonist | 0.144 0.035 CID_6453821 | ||
| 0.281 | 0.014 | 0.281 | Cholesterol synthesis inhibitor | 0.217 0.023 CID_6453821 | ||
| 0.285 | 0.018 | 0.285 | Alpha-N-acetylglucosaminidase inhibitor | 0.253 0.022 CID_6453821 | ||
| 0.271 | 0.008 | 0.271 | NMDA receptor antagonist | 0.2 0.014 CID_6453821 | ||
| 0.3 | 0.037 | 0.549 | Peroxidase inhibitor | 0.549 0.006 CID_6453821 | CID_6453821 | |
| 0.266 | 0.005 | 0.266 | Nav1.8 sodium channel blocker | 0.226 0.005 CID_6453821 | ||
| 0.292 | 0.035 | 0.292 | 5 Hydroxytryptamine 1E antagonist | 0.239 0.087 CID_6453821 | ||
| 0.263 | 0.007 | 0.263 | CC chemokine receptor antagonist | 0.124 0.025 CID_6453821 | ||
| 0.29 | 0.036 | 0.29 | MAP-kinase-activated kinase 5 inhibitor | 0.167 0.153 CID_6453821 | ||
| 0.258 | 0.005 | 0.258 | Adrenaline uptake inhibitor | 0.128 0.013 CID_6453821 | ||
| 0.278 | 0.025 | 0.278 | Neurotrophic factor enhancer | 0.254 0.036 CID_6453821 | ||
| 0.261 | 0.008 | 0.261 | 5 Hydroxytryptamine uptake inhibitor | 0.086 0.032 CID_6453821 | ||
| 0.261 | 0.011 | 0.261 | ATPase inhibitor | 0.213 0.028 CID_6453821 | ||
| 0.295 | 0.05 | 0.295 | HERG channel blocker | |||
| 0.255 | 0.011 | 0.275 | Mannose-6-phosphate isomerase inhibitor | 0.275 0.008 CID_6453821 | CID_6453821 | |
| 0.253 | 0.013 | 0.393 | UDP-glucose 4-epimerase inhibitor | 0.393 0.006 CID_6453821 | CID_6453821 | |
| 0.248 | 0.012 | 0.248 | GABA C receptor rho-2 antagonist | 0.185 0.038 CID_6453821 | ||
| 0.287 | 0.051 | 0.287 | Potassium channel blocker | |||
| 0.28 | 0.044 | 0.302 | Tyrosine 3 hydroxylase inhibitor | 0.302 0.032 CID_6453821 | CID_6453821 | |
| 0.247 | 0.014 | 0.247 | Ferrochelatase inhibitor | 0.155 0.036 CID_6453821 | ||
| 0.245 | 0.012 | 0.245 | Catenin beta inhibitor | 0.191 0.04 CID_6453821 | ||
| 0.257 | 0.028 | 0.257 | Nitric-oxide synthase stimulant | 0.244 0.036 CID_6453821 | ||
| 0.326 | 0.099 | 0.326 | Calpain 2 inhibitor | 0.216 0.174 CID_6453821 | ||
| 0.235 | 0.012 | 0.235 | 5 Hydroxytryptamine agonist | |||
| 0.239 | 0.018 | 0.239 | Sodium channel (voltage-gated) blocker | 0.179 0.038 CID_6453821 | ||
| 0.26 | 0.039 | 0.26 | Non-steroidal antiinflammatory agent | 0.185 0.083 CID_6453821 | ||
| 0.226 | 0.005 | 0.226 | Sphingosine 1-phosphate receptor 4 antagonist | 0.167 0.021 CID_6453821 | ||
| 0.225 | 0.004 | 0.238 | NMDA receptor subunit 3B antagonist | 0.238 0.004 CID_6453821 | CID_6453821 | |
| 0.224 | 0.006 | 0.224 | Electrolyte absorption antagonist | 0.171 0.013 CID_6453821 | ||
| 0.239 | 0.021 | 0.239 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.123 CID_6453821 | ||
| 0.221 | 0.004 | 0.221 | NMDA receptor agonist | 0.14 0.009 CID_6453821 | ||
| 0.226 | 0.009 | 0.226 | 5 Hydroxytryptamine 3A agonist | 0.133 0.046 CID_6453821 | ||
| 0.356 | 0.141 | 0.356 | Caspase 9 stimulant | 0.303 0.191 CID_6453821 | ||
| 0.236 | 0.022 | 0.236 | Sodium channel blocker | 0.173 0.043 CID_6453821 | ||
| 0.218 | 0.005 | 0.218 | Cannabinoid CB2 receptor antagonist | 0.11 0.012 CID_6453821 | ||
| 0.245 | 0.034 | 0.245 | Amyloid beta precursor protein antagonist | 0.183 0.069 CID_6453821 | ||
| 0.216 | 0.006 | 0.216 | CYP2A6 inhibitor | 0.109 0.031 CID_6453821 | ||
| 0.238 | 0.031 | 0.432 | Heat shock protein 90 alpha antagonist | 0.432 0.005 CID_6453821 | CID_6453821 | |
| 0.29 | 0.085 | 0.34 | 12-Lipoxygenase inhibitor | 0.34 0.061 CID_6453821 | CID_6453821 | |
| 0.237 | 0.033 | 0.237 | 3C-like protease (Human coronavirus) inhibitor | 0.162 0.084 CID_6453821 | ||
| 0.21 | 0.009 | 0.21 | Pregnane X receptor agonist | 0.16 0.037 CID_6453821 | ||
| 0.203 | 0.004 | 0.203 | 5 Hydroxytryptamine 2 agonist | 0.15 0.005 CID_6453821 | ||
| 0.226 | 0.027 | 0.226 | NADPH oxidase inhibitor | 0.153 0.053 CID_6453821 | ||
| 0.216 | 0.017 | 0.216 | MAP kinase 13 inhibitor | |||
| 0.215 | 0.018 | 0.215 | GABA C receptor agonist | 0.206 0.019 CID_6453821 | ||
| 0.207 | 0.011 | 0.207 | Interleukin 8 antagonist | 0.186 0.017 CID_6453821 | ||
| 0.215 | 0.02 | 0.217 | Arachidonic acid antagonist | 0.217 0.019 CID_6453821 | CID_6453821 | |
| 0.221 | 0.028 | 0.221 | Nav1.2 sodium channel blocker | 0.127 0.075 CID_6453821 | ||
| 0.213 | 0.02 | 0.213 | Nav1.3 sodium channel blocker | 0.157 0.044 CID_6453821 | ||
| 0.196 | 0.006 | 0.196 | Cyclin B3 inhibitor | 0.158 0.012 CID_6453821 | ||
| 0.246 | 0.06 | 0.246 | Neuropeptide Y2 antagonist | 0.196 0.126 CID_6453821 | ||
| 0.197 | 0.012 | 0.197 | HIV-1 integrase (Overall Integration) inhibitor | 0.184 0.015 CID_6453821 | ||
| 0.213 | 0.029 | 0.213 | Alkaline phosphatase inhibitor | 0.198 0.034 CID_6453821 | ||
| 0.186 | 0.003 | 0.186 | NMDA receptor glycine site agonist | 0.135 0.005 CID_6453821 | ||
| 0.201 | 0.018 | 0.201 | Carbonic anhydrase XV inhibitor | 0.171 0.024 CID_6453821 | ||
| 0.194 | 0.014 | 0.194 | Nav1.5 sodium channel blocker | 0.137 0.036 CID_6453821 | ||
| 0.184 | 0.005 | 0.184 | Ca2+-transporting ATPase inhibitor | 0.174 0.01 CID_6453821 | ||
| 0.183 | 0.004 | 0.183 | NMDA receptor subunit 3A antagonist | 0.172 0.004 CID_6453821 | ||
| 0.253 | 0.075 | 0.253 | Gastrin inhibitor | |||
| 0.205 | 0.028 | 0.22 | Cell wall synthesis inhibitor | 0.22 0.023 CID_6453821 | CID_6453821 | |
| 0.21 | 0.033 | 0.412 | Heat shock protein 90 antagonist | 0.412 0.004 CID_6453821 | CID_6453821 | |
| 0.199 | 0.023 | 0.199 | MAP kinase 12 inhibitor | |||
| 0.19 | 0.015 | 0.19 | DNA directed RNA polymerase inhibitor | 0.176 0.017 CID_6453821 | ||
| 0.214 | 0.04 | 0.214 | Antipruritic | 0.19 0.056 CID_6453821 | ||
| 0.19 | 0.016 | 0.19 | EphA2 antagonist | 0.132 0.043 CID_6453821 | ||
| 0.175 | 0.004 | 0.175 | 5 Hydroxytryptamine 2C agonist | 0.101 0.008 CID_6453821 | ||
| 0.185 | 0.016 | 0.185 | GABA C receptor antagonist | 0.153 0.028 CID_6453821 | ||
| 0.182 | 0.014 | 0.182 | Hedgehog signaling inhibitor | |||
| 0.209 | 0.041 | 0.209 | Amylase inhibitor | 0.209 0.041 CID_6453821 | ||
| 0.207 | 0.041 | 0.207 | Diuretic | 0.188 0.049 CID_6453821 | ||
| 0.189 | 0.024 | 0.189 | Nav1.6 sodium channel blocker | 0.141 0.065 CID_6453821 | ||
| 0.168 | 0.005 | 0.168 | Dopamine transporter inhibitor | 0.091 0.014 CID_6453821 | ||
| 0.171 | 0.01 | 0.183 | MAP kinase kinase 1 inhibitor | 0.183 0.007 CID_6453821 | CID_6453821 | |
| 0.216 | 0.056 | 0.216 | LIM domain kinase 1 inhibitor | 0.167 0.082 CID_6453821 | ||
| 0.173 | 0.013 | 0.186 | NADH dehydrogenase inhibitor | 0.186 0.012 CID_6453821 | CID_6453821 | |
| 0.168 | 0.009 | 0.168 | Prostaglandin-E synthase inhibitor | 0.113 0.021 CID_6453821 | ||
| 0.242 | 0.085 | 0.242 | Interleukin agonist | 0.174 0.145 CID_6453821 | ||
| 0.18 | 0.024 | 0.18 | Sphingosine 1-phosphate receptor 5 antagonist | 0.176 0.028 CID_6453821 | ||
| 0.162 | 0.006 | 0.162 | Potassium channel Kv1.5 blocker | |||
| 0.172 | 0.017 | 0.183 | AMP-activated protein kinase stimulant | 0.183 0.014 CID_6453821 | CID_6453821 | |
| 0.223 | 0.068 | 0.223 | MAP kinase kinase 2 inhibitor | 0.146 0.125 CID_6453821 | ||
| 0.163 | 0.009 | 0.163 | Dopamine uptake inhibitor | 0.092 0.021 CID_6453821 | ||
| 0.161 | 0.008 | 0.161 | Prostaglandin E2 antagonist | |||
| 0.156 | 0.003 | 0.156 | Exportin-1 inhibitor | 0.107 0.007 CID_6453821 | ||
| 0.222 | 0.069 | 0.222 | ErbB-1 antagonist | 0.185 0.108 CID_6453821 | ||
| 0.17 | 0.018 | 0.17 | Beta glucuronidase inhibitor | 0.155 0.022 CID_6453821 | ||
| 0.284 | 0.133 | 0.284 | Histamine release inhibitor | 0.211 0.189 CID_6453821 | ||
| 0.166 | 0.016 | 0.166 | GABA C receptor rho-1 antagonist | 0.118 0.042 CID_6453821 | ||
| 0.167 | 0.018 | 0.185 | Creatine kinase inhibitor | 0.185 0.013 CID_6453821 | CID_6453821 | |
| 0.156 | 0.006 | 0.156 | Glycine receptor antagonist | 0.116 0.02 CID_6453821 | ||
| 0.169 | 0.022 | 0.169 | Sphingosine 1-phosphate receptor 2 antagonist | 0.169 0.022 CID_6453821 | ||
| 0.18 | 0.035 | 0.18 | MAP kinase 3 inhibitor | 0.138 0.09 CID_6453821 | ||
| 0.177 | 0.032 | 0.177 | Neuropeptide Y1 antagonist | 0.155 0.057 CID_6453821 | ||
| 0.184 | 0.04 | 0.261 | c-Src kinase inhibitor | 0.261 0.023 CID_6453821 | CID_6453821 | |
| 0.179 | 0.037 | 0.204 | MAP kinase kinase inhibitor | 0.204 0.027 CID_6453821 | CID_6453821 | |
| 0.186 | 0.044 | 0.186 | Hexokinase inhibitor | 0.143 0.087 CID_6453821 | ||
| 0.188 | 0.049 | 0.188 | Interleukin 6 antagonist | |||
| 0.148 | 0.008 | 0.148 | Benzodiazepine agonist | 0.064 0.06 CID_6453821 | ||
| 0.153 | 0.014 | 0.153 | Cell adhesion molecule inhibitor | |||
| 0.147 | 0.008 | 0.147 | GABA aminotransferase inhibitor | 0.132 0.012 CID_6453821 | ||
| 0.226 | 0.088 | 0.226 | Calpain inhibitor | 0.197 0.116 CID_6453821 | ||
| 0.155 | 0.019 | 0.155 | Potassium channel activator | 0.09 0.061 CID_6453821 | ||
| 0.181 | 0.048 | 0.181 | Thiol protease inhibitor | 0.144 0.075 CID_6453821 | ||
| 0.141 | 0.007 | 0.141 | D-Ala-D-Ala ligase inhibitor | 0.135 0.008 CID_6453821 | ||
| 0.149 | 0.017 | 0.149 | NMDA 2 receptor antagonist | 0.114 0.026 CID_6453821 | ||
| 0.136 | 0.005 | 0.136 | GABA B receptor agonist | 0.124 0.007 CID_6453821 | ||
| 0.191 | 0.061 | 0.191 | Mcl-1 antagonist | 0.177 0.069 CID_6453821 | ||
| 0.134 | 0.005 | 0.134 | Potassium channel intermediate-conductance Ca-activated blocker | 0.055 0.053 CID_6453821 | ||
| 0.18 | 0.05 | 0.2 | Interferon gamma antagonist | 0.2 0.041 CID_6453821 | CID_6453821 | |
| 0.154 | 0.025 | 0.154 | Catalase inhibitor | 0.087 0.044 CID_6453821 | ||
| 0.17 | 0.042 | 0.17 | Cyclooxygenase 2 inhibitor | 0.138 0.064 CID_6453821 | ||
| 0.223 | 0.095 | 0.223 | Superoxide dismutase inhibitor | 0.211 0.105 CID_6453821 | ||
| 0.131 | 0.003 | 0.131 | CC chemokine 4 receptor antagonist | 0.065 0.013 CID_6453821 | ||
| 0.253 | 0.126 | 0.291 | Transcription factor NF kappa B inhibitor | 0.291 0.099 CID_6453821 | CID_6453821 | |
| 0.165 | 0.038 | 0.165 | Cell adhesion inhibitor | |||
| 0.144 | 0.019 | 0.144 | Glutamate receptor agonist | 0.094 0.042 CID_6453821 | ||
| 0.177 | 0.052 | 0.177 | Cyclooxygenase inhibitor | 0.146 0.073 CID_6453821 | ||
| 0.209 | 0.084 | 0.209 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.144 | 0.021 | 0.144 | Interleukin 2 antagonist | |||
| 0.156 | 0.033 | 0.156 | GABA receptor agonist | |||
| 0.135 | 0.011 | 0.135 | T cell inhibitor | 0.094 0.031 CID_6453821 | ||
| 0.144 | 0.022 | 0.185 | Alcohol dehydrogenase inhibitor | 0.185 0.014 CID_6453821 | CID_6453821 | |
| 0.135 | 0.013 | 0.135 | Nav1.7 sodium channel blocker | 0.08 0.033 CID_6453821 | ||
| 0.27 | 0.149 | 0.27 | 15-Lipoxygenase inhibitor | 0.265 0.153 CID_6453821 | ||
| 0.133 | 0.012 | 0.133 | Cannabinoid CB1 receptor agonist | |||
| 0.212 | 0.092 | 0.22 | Antiamyloidogenic | 0.22 0.086 CID_6453821 | CID_6453821 | |
| 0.175 | 0.056 | 0.175 | Neurotensin receptor agonist | 0.161 0.078 CID_6453821 | ||
| 0.128 | 0.009 | 0.128 | Phosphorylase inhibitor | 0.064 0.023 CID_6453821 | ||
| 0.127 | 0.008 | 0.127 | 5 Hydroxytryptamine 2A agonist | 0.101 0.014 CID_6453821 | ||
| 0.137 | 0.019 | 0.137 | Histamine N-methyltransferase inhibitor | 0.081 0.065 CID_6453821 | ||
| 0.122 | 0.005 | 0.122 | Glutamate (mGluR6) antagonist | 0.098 0.011 CID_6453821 | ||
| 0.143 | 0.027 | 0.158 | Urease inhibitor | 0.158 0.019 CID_6453821 | CID_6453821 | |
| 0.144 | 0.028 | 0.166 | Transcription factor STAT6 inhibitor | 0.166 0.014 CID_6453821 | CID_6453821 | |
| 0.12 | 0.004 | 0.12 | Corticotropin releasing factor 2 receptor antagonist | 0.079 0.018 CID_6453821 | ||
| 0.121 | 0.007 | 0.121 | Vanilloid 4 agonist | 0.083 0.035 CID_6453821 | ||
| 0.141 | 0.027 | 0.146 | DOPA decarboxylase inhibitor | 0.146 0.023 CID_6453821 | CID_6453821 | |
| 0.175 | 0.062 | 0.175 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.132 | 0.02 | 0.132 | Glutamate (mGluR7) agonist | 0.096 0.069 CID_6453821 | ||
| 0.117 | 0.006 | 0.117 | Kainate receptor antagonist | 0.064 0.014 CID_6453821 | ||
| 0.114 | 0.004 | 0.151 | Glucagon receptor antagonist | 0.151 0.003 CID_6453821 | CID_6453821 | |
| 0.12 | 0.009 | 0.12 | NMDA 2A receptor antagonist | 0.082 0.019 CID_6453821 | ||
| 0.113 | 0.004 | 0.113 | NMDA receptor glycine site antagonist | 0.059 0.005 CID_6453821 | ||
| 0.115 | 0.005 | 0.115 | Nicotinic alpha3beta2 receptor antagonist | 0.067 0.02 CID_6453821 | ||
| 0.151 | 0.043 | 0.151 | Heat shock protein 70 antagonist | 0.137 0.089 CID_6453821 | ||
| 0.112 | 0.004 | 0.112 | 5 Hydroxytryptamine 2B agonist | 0.06 0.009 CID_6453821 | ||
| 0.132 | 0.026 | 0.132 | Triose-phosphate isomerase inhibitor | 0.121 0.032 CID_6453821 | ||
| 0.109 | 0.004 | 0.109 | Potassium channel small-conductance Ca-activated activator | |||
| 0.151 | 0.048 | 0.151 | Cyclooxygenase 3 inhibitor | 0.102 0.1 CID_6453821 | ||
| 0.12 | 0.017 | 0.12 | Sphingosine 1-phosphate receptor 4 agonist | 0.104 0.023 CID_6453821 | ||
| 0.114 | 0.012 | 0.114 | NMDA 2C receptor antagonist | 0.089 0.02 CID_6453821 | ||
| 0.107 | 0.004 | 0.107 | Kainate receptor 2 antagonist | 0.067 0.009 CID_6453821 | ||
| 0.107 | 0.005 | 0.107 | Glucagon-like peptide 1 receptor antagonist | 0.051 0.013 CID_6453821 | ||
| 0.106 | 0.004 | 0.106 | Potassium channel (Inward rectifier) activator | 0.063 0.017 CID_6453821 | ||
| 0.106 | 0.005 | 0.106 | MDM2 inhibitor | 0.082 0.017 CID_6453821 | ||
| 0.103 | 0.004 | 0.103 | Potassium channel (ATP-sensitive) activator | 0.06 0.016 CID_6453821 | ||
| 0.112 | 0.015 | 0.112 | Prostaglandin antagonist | |||
| 0.114 | 0.017 | 0.114 | Purinergic P2 antagonist | |||
| 0.12 | 0.025 | 0.12 | Protein kinase B gamma inhibitor | |||
| 0.145 | 0.05 | 0.145 | Aldehyde dehydrogenase inhibitor | 0.134 0.058 CID_6453821 | ||
| 0.121 | 0.027 | 0.121 | MAP kinase 14 inhibitor | |||
| 0.115 | 0.021 | 0.115 | Cannabinoid receptor agonist | |||
| 0.098 | 0.004 | 0.115 | Pregnane X receptor antagonist | 0.115 0.003 CID_6453821 | CID_6453821 | |
| 0.214 | 0.12 | 0.281 | Transcription factor STAT inhibitor | 0.281 0.067 CID_6453821 | CID_6453821 | |
| 0.131 | 0.037 | 0.131 | Falcipain 2 inhibitor | |||
| 0.195 | 0.103 | 0.195 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.167 0.123 CID_6453821 | ||
| 0.101 | 0.009 | 0.101 | Botulinum neurotoxin type A inhibitor | 0.08 0.017 CID_6453821 | ||
| 0.104 | 0.011 | 0.104 | AMPA receptor antagonist | 0.049 0.032 CID_6453821 | ||
| 0.157 | 0.065 | 0.157 | CF transmembrane conductance regulator agonist | 0.138 0.1 CID_6453821 | ||
| 0.131 | 0.039 | 0.131 | Falcipain inhibitor | |||
| 0.122 | 0.031 | 0.138 | Protein kinase C zeta inhibitor | 0.138 0.023 CID_6453821 | CID_6453821 | |
| 0.118 | 0.027 | 0.118 | MAP kinase 11 inhibitor | |||
| 0.149 | 0.057 | 0.149 | Cyclooxygenase 1 inhibitor | 0.124 0.076 CID_6453821 | ||
| 0.137 | 0.046 | 0.137 | Alpha 2b adrenoreceptor antagonist | |||
| 0.103 | 0.013 | 0.103 | Phospholipase D inhibitor | 0.071 0.051 CID_6453821 | ||
| 0.205 | 0.115 | 0.255 | DNA synthesis inhibitor | 0.255 0.063 CID_6453821 | CID_6453821 | |
| 0.093 | 0.004 | 0.093 | Benzodiazepine antagonist | 0.055 0.019 CID_6453821 | ||
| 0.114 | 0.026 | 0.115 | Bile acid receptor antagonist | 0.115 0.025 CID_6453821 | CID_6453821 | |
| 0.21 | 0.122 | 0.21 | Transcription factor STAT3 inhibitor | 0.205 0.128 CID_6453821 | ||
| 0.105 | 0.018 | 0.105 | Glycine receptor agonist | 0.09 0.028 CID_6453821 | ||
| 0.09 | 0.003 | 0.09 | Corticotropin releasing factor 1 receptor antagonist | 0.051 0.005 CID_6453821 | ||
| 0.14 | 0.054 | 0.14 | Cathepsin H inhibitor | |||
| 0.09 | 0.004 | 0.09 | Kynurenine 3 monooxygenase inhibitor | 0.066 0.005 CID_6453821 | ||
| 0.124 | 0.038 | 0.124 | Sphingomyelinase inhibitor | 0.103 0.056 CID_6453821 | ||
| 0.119 | 0.034 | 0.172 | Androgen antagonist | 0.172 0.017 CID_6453821 | CID_6453821 | |
| 0.09 | 0.005 | 0.09 | Purinergic P2X7 antagonist | |||
| 0.113 | 0.028 | 0.113 | Bromodomain-containing protein 2 inhibitor | |||
| 0.088 | 0.004 | 0.088 | Alpha 1L adrenoreceptor agonist | 0.045 0.026 CID_6453821 | ||
| 0.096 | 0.011 | 0.096 | Potassium channel (Tandem pore domain) blocker | |||
| 0.13 | 0.045 | 0.13 | Protein kinase C gamma inhibitor | 0.095 0.086 CID_6453821 | ||
| 0.089 | 0.005 | 0.089 | Glutamate (mGluR3) antagonist | 0.048 0.014 CID_6453821 | ||
| 0.094 | 0.01 | 0.094 | Purinergic P2X antagonist | |||
| 0.101 | 0.017 | 0.101 | TRPA1 antagonist | 0.063 0.039 CID_6453821 | ||
| 0.108 | 0.025 | 0.108 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.112 | 0.028 | 0.112 | p38 MAP kinase inhibitor | |||
| 0.159 | 0.077 | 0.183 | Src kinase inhibitor | 0.183 0.063 CID_6453821 | CID_6453821 | |
| 0.128 | 0.046 | 0.128 | Ephrin antagonist | 0.109 0.056 CID_6453821 | ||
| 0.223 | 0.143 | 0.354 | Prostaglandin dehydrogenase inhibitor | 0.354 0.081 CID_6453821 | CID_6453821 | |
| 0.093 | 0.013 | 0.093 | Dihydroorotate dehydrogenase inhibitor | 0.063 0.026 CID_6453821 | ||
| 0.163 | 0.083 | 0.19 | Phospholipase C inhibitor | 0.19 0.051 CID_6453821 | CID_6453821 | |
| 0.087 | 0.007 | 0.087 | CC chemokine receptor 2B antagonist | |||
| 0.091 | 0.012 | 0.091 | Neurokinin 2 antagonist | |||
| 0.119 | 0.039 | 0.119 | Ca(v)2.2 blocker | |||
| 0.083 | 0.004 | 0.116 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.116 0.002 CID_6453821 | CID_6453821 | |
| 0.176 | 0.098 | 0.195 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.195 0.077 CID_6453821 | CID_6453821 | |
| 0.095 | 0.017 | 0.095 | GABA A receptor antagonist | |||
| 0.095 | 0.017 | 0.095 | GABA receptor antagonist | |||
| 0.146 | 0.069 | 0.146 | Adenylate cyclase stimulant | 0.146 0.069 CID_6453821 | ||
| 0.082 | 0.004 | 0.082 | LFA antagonist | 0.027 0.021 CID_6453821 | ||
| 0.081 | 0.004 | 0.085 | Somatostatin 2 agonist | 0.085 0.004 CID_6453821 | CID_6453821 | |
| 0.252 | 0.175 | 0.325 | Antibacterial | 0.325 0.118 CID_6453821 | CID_6453821 | |
| 0.145 | 0.07 | 0.154 | Glycogen synthase kinase-3 alpha inhibitor | 0.154 0.064 CID_6453821 | CID_6453821 | |
| 0.087 | 0.012 | 0.087 | Sphingosine kinase 2 inhibitor | 0.063 0.028 CID_6453821 | ||
| 0.212 | 0.138 | 0.237 | Hypoxia-inducible factor 1 alpha inhibitor | 0.237 0.113 CID_6453821 | CID_6453821 | |
| 0.151 | 0.078 | 0.151 | Cyclin-dependent kinase 8 inhibitor | 0.128 0.106 CID_6453821 | ||
| 0.118 | 0.045 | 0.118 | Adenylate kinase inhibitor | 0.112 0.052 CID_6453821 | ||
| 0.116 | 0.043 | 0.121 | Anabolic | 0.121 0.038 CID_6453821 | CID_6453821 | |
| 0.093 | 0.02 | 0.093 | Cannabinoid CB2 receptor agonist | |||
| 0.123 | 0.051 | 0.123 | Aminopeptidase B inhibitor | 0.114 0.056 CID_6453821 | ||
| 0.084 | 0.012 | 0.084 | Calcium channel P-type blocker | |||
| 0.128 | 0.057 | 0.141 | Protein kinase (CK2) alpha inhibitor | 0.141 0.047 CID_6453821 | CID_6453821 | |
| 0.083 | 0.012 | 0.083 | 5 Hydroxytryptamine 7 agonist | |||
| 0.079 | 0.009 | 0.079 | Somatostatin agonist | 0.059 0.011 CID_6453821 | ||
| 0.074 | 0.005 | 0.074 | p53 inhibitor | |||
| 0.078 | 0.009 | 0.078 | Dihydroorotase inhibitor | 0.052 0.022 CID_6453821 | ||
| 0.173 | 0.104 | 0.173 | Insulin sensitizer | 0.155 0.126 CID_6453821 | ||
| 0.092 | 0.023 | 0.092 | Bcl2 antagonist | 0.065 0.048 CID_6453821 | ||
| 0.073 | 0.004 | 0.073 | Heme oxygenase inhibitor | 0.046 0.02 CID_6453821 | ||
| 0.094 | 0.025 | 0.094 | Sphingosine 1-phosphate receptor antagonist | 0.083 0.039 CID_6453821 | ||
| 0.073 | 0.004 | 0.152 | ATP citrate lysase inhibitor | 0.152 0.003 CID_6453821 | CID_6453821 | |
| 0.084 | 0.015 | 0.084 | Glycine transporter inhibitor | |||
| 0.138 | 0.07 | 0.138 | Calcium channel blocker | |||
| 0.075 | 0.007 | 0.075 | Glutamate (mGluR group II) antagonist | 0.053 0.014 CID_6453821 | ||
| 0.071 | 0.005 | 0.071 | Phenylethanolamine N methyltransferase inhibitor | 0.045 0.021 CID_6453821 | ||
| 0.098 | 0.032 | 0.098 | Glutamate dehydrogenase inhibitor | 0.096 0.033 CID_6453821 | ||
| 0.075 | 0.009 | 0.075 | Factor XIa inhibitor | |||
| 0.077 | 0.011 | 0.077 | Glutamate (mGluR5) agonist | |||
| 0.116 | 0.051 | 0.13 | Protein kinase (CK2) inhibitor | 0.13 0.042 CID_6453821 | CID_6453821 | |
| 0.07 | 0.005 | 0.07 | Factor XI inhibitor | |||
| 0.085 | 0.02 | 0.085 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.089 | 0.024 | 0.089 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.083 | 0.019 | 0.201 | Heat shock protein 90 beta antagonist | 0.201 0.004 CID_6453821 | CID_6453821 | |
| 0.077 | 0.013 | 0.077 | CD45 antagonist | 0.067 0.017 CID_6453821 | ||
| 0.208 | 0.144 | 0.211 | Insulysin inhibitor | 0.211 0.141 CID_6453821 | CID_6453821 | |
| 0.075 | 0.012 | 0.075 | Progesterone antagonist | 0.054 0.017 CID_6453821 | ||
| 0.113 | 0.049 | 0.113 | Carbonic anhydrase III inhibitor | 0.102 0.06 CID_6453821 | ||
| 0.092 | 0.029 | 0.092 | Calcium channel L-type blocker | |||
| 0.123 | 0.059 | 0.123 | Calcium channel N-type blocker | |||
| 0.094 | 0.031 | 0.22 | Estrogen receptor alpha antagonist | 0.22 0.007 CID_6453821 | CID_6453821 | |
| 0.073 | 0.011 | 0.073 | Adenylate cyclase 1 inhibitor | 0.043 0.037 CID_6453821 | ||
| 0.085 | 0.022 | 0.108 | Purinergic P2X1 antagonist | 0.108 0.014 CID_6453821 | CID_6453821 | |
| 0.087 | 0.025 | 0.087 | Carbamoyl phosphate synthetase inhibitor | 0.082 0.028 CID_6453821 | ||
| 0.089 | 0.029 | 0.177 | Dopamine D1 antagonist | 0.177 0.012 CID_6453821 | CID_6453821 | |
| 0.093 | 0.034 | 0.106 | HIV-1 reverse transcriptase inhibitor | 0.106 0.028 CID_6453821 | CID_6453821 | |
| 0.099 | 0.041 | 0.099 | ATPase (Vacuolar H+) inhibitor | 0.095 0.047 CID_6453821 | ||
| 0.089 | 0.031 | 0.089 | Amidase inhibitor | |||
| 0.062 | 0.004 | 0.062 | Integrin alpha1beta1 antagonist | 0.043 0.015 CID_6453821 | ||
| 0.101 | 0.045 | 0.101 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.117 | 0.061 | 0.364 | Estrogen antagonist | 0.364 0.005 CID_6453821 | CID_6453821 | |
| 0.064 | 0.007 | 0.064 | Nerve growth factor antagonist | 0.042 0.031 CID_6453821 | ||
| 0.061 | 0.005 | 0.061 | Benzodiazepine receptor peripheral-type antagonist | 0.033 0.027 CID_6453821 | ||
| 0.117 | 0.061 | 0.117 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.06 | 0.005 | 0.078 | CF transmembrane conductance regulator antagonist | 0.078 0.003 CID_6453821 | CID_6453821 | |
| 0.071 | 0.016 | 0.071 | Glutamate (mGluR group I) agonist | |||
| 0.06 | 0.005 | 0.06 | Protein kinase (CK2) beta inhibitor | 0.042 0.011 CID_6453821 | ||
| 0.08 | 0.026 | 0.08 | Biliverdin reductase inhibitor | 0.061 0.039 CID_6453821 | ||
| 0.11 | 0.055 | 0.11 | MAO B inhibitor | 0.107 0.057 CID_6453821 | ||
| 0.106 | 0.052 | 0.38 | Estrogen receptor beta antagonist | 0.38 0.004 CID_6453821 | CID_6453821 | |
| 0.139 | 0.086 | 0.139 | Insulin secretagoues | |||
| 0.066 | 0.014 | 0.066 | Fructose-1,6-bisphosphatase inhibitor | 0.041 0.037 CID_6453821 | ||
| 0.127 | 0.076 | 0.127 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.057 | 0.007 | 0.057 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.039 0.012 CID_6453821 | ||
| 0.096 | 0.046 | 0.096 | Interleukin 5 antagonist | |||
| 0.212 | 0.163 | 0.212 | Antithrombotic | |||
| 0.055 | 0.005 | 0.055 | Vanilloid 3 antagonist | 0.041 0.02 CID_6453821 | ||
| 0.061 | 0.012 | 0.061 | GABA B receptor antagonist | |||
| 0.068 | 0.019 | 0.068 | Aconitate hydratase inhibitor | 0.057 0.029 CID_6453821 | ||
| 0.054 | 0.005 | 0.062 | CXC chemokine 2 receptor antagonist | 0.062 0.005 CID_6453821 | CID_6453821 | |
| 0.137 | 0.089 | 0.137 | Phospholipase A2 inhibitor | 0.134 0.094 CID_6453821 | ||
| 0.068 | 0.019 | 0.068 | Dihydroorotate oxidase inhibitor | 0.056 0.036 CID_6453821 | ||
| 0.101 | 0.052 | 0.101 | Potassium channel (Voltage-sensitive) activator | |||
| 0.052 | 0.004 | 0.052 | Dipeptidyl peptidase IX inhibitor | 0.015 0.012 CID_6453821 | ||
| 0.159 | 0.111 | 0.159 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.081 | 0.035 | 0.081 | Secretase beta inhibitor | |||
| 0.117 | 0.07 | 0.154 | Adenylate cyclase inhibitor | 0.154 0.043 CID_6453821 | CID_6453821 | |
| 0.092 | 0.045 | 0.092 | Carbonic anhydrase VI inhibitor | 0.087 0.049 CID_6453821 | ||
| 0.085 | 0.038 | 0.092 | Phosphofructokinase-1 inhibitor | 0.092 0.035 CID_6453821 | CID_6453821 | |
| 0.088 | 0.042 | 0.088 | Transforming growth factor beta 3 antagonist | |||
| 0.05 | 0.004 | 0.05 | Sodium/hydrogen exchanger inhibitor | 0.018 0.012 CID_6453821 | ||
| 0.082 | 0.036 | 0.09 | Phenylalanine 4-hydroxylase inhibitor | 0.09 0.031 CID_6453821 | CID_6453821 | |
| 0.089 | 0.043 | 0.089 | Alpha 2a adrenoreceptor antagonist | |||
| 0.076 | 0.03 | 0.076 | 5 Hydroxytryptamine 3 agonist | |||
| 0.069 | 0.023 | 0.069 | Dopamine D4 agonist | |||
| 0.139 | 0.094 | 0.139 | Sigma receptor agonist | |||
| 0.053 | 0.008 | 0.053 | Glutamate (mGluR2) antagonist | 0.035 0.014 CID_6453821 | ||
| 0.087 | 0.042 | 0.116 | Porphobilinogen synthase inhibitor | 0.116 0.029 CID_6453821 | CID_6453821 | |
| 0.068 | 0.023 | 0.068 | Bcl-xL inhibitor | 0.062 0.035 CID_6453821 | ||
| 0.057 | 0.012 | 0.057 | Dihydrofolate reductase inhibitor | 0.049 0.02 CID_6453821 | ||
| 0.071 | 0.026 | 0.102 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.102 0.01 CID_6453821 | CID_6453821 | |
| 0.063 | 0.018 | 0.063 | Farnesyltransferase inhibitor | |||
| 0.051 | 0.006 | 0.051 | Ceramide glucosyltransferase inhibitor | 0.045 0.011 CID_6453821 | ||
| 0.112 | 0.068 | 0.112 | TRPA1 agonist | |||
| 0.06 | 0.016 | 0.068 | Nicotinic acid receptor 1 agonist | 0.068 0.014 CID_6453821 | CID_6453821 | |
| 0.055 | 0.011 | 0.055 | Potassium channel Kv1.1 blocker | |||
| 0.07 | 0.026 | 0.07 | Fatty acid synthase inhibitor | 0.07 0.026 CID_6453821 | ||
| 0.071 | 0.027 | 0.071 | Kallikrein 7 inhibitor | |||
| 0.053 | 0.01 | 0.053 | Integrin alpha2 antagonist | |||
| 0.055 | 0.013 | 0.055 | Alpha 1d adrenoreceptor agonist | |||
| 0.059 | 0.016 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.067 0.009 CID_6453821 | CID_6453821 | |
| 0.06 | 0.018 | 0.06 | Glucose-6-phosphate isomerase inhibitor | 0.06 0.018 CID_6453821 | ||
| 0.072 | 0.029 | 0.072 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.09 | 0.048 | 0.09 | Glutathione S-transferase inhibitor | 0.085 0.053 CID_6453821 | ||
| 0.111 | 0.069 | 0.111 | Calcium channel (voltage-sensitive) blocker | |||
| 0.061 | 0.019 | 0.061 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.133 | 0.091 | 0.133 | Hemostatic | |||
| 0.062 | 0.02 | 0.062 | Immunoglobulin Fc receptor antagonist | |||
| 0.05 | 0.009 | 0.05 | Free fatty acid receptor 1 antagonist | 0.046 0.011 CID_6453821 | ||
| 0.109 | 0.068 | 0.109 | Acetylcholine release stimulant | |||
| 0.124 | 0.083 | 0.124 | Interleukin 1 antagonist | |||
| 0.061 | 0.021 | 0.061 | Heparanase inhibitor | 0.053 0.036 CID_6453821 | ||
| 0.055 | 0.014 | 0.073 | Dopamine D5 agonist | 0.073 0.007 CID_6453821 | CID_6453821 | |
| 0.053 | 0.013 | 0.053 | AMPA 4 receptor antagonist | 0.04 0.027 CID_6453821 | ||
| 0.163 | 0.123 | 0.163 | Histone acetyltransferase inhibitor | |||
| 0.06 | 0.022 | 0.06 | Antiviral (Hepatitis D) | 0.047 0.044 CID_6453821 | ||
| 0.067 | 0.028 | 0.067 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.069 | 0.031 | 0.095 | Androgen agonist | 0.095 0.017 CID_6453821 | CID_6453821 | |
| 0.053 | 0.015 | 0.053 | Histamine H1 receptor agonist | |||
| 0.044 | 0.006 | 0.044 | 5 Hydroxytryptamine 6 agonist | |||
| 0.044 | 0.006 | 0.044 | Kainate receptor 1 antagonist | 0.021 0.015 CID_6453821 | ||
| 0.064 | 0.026 | 0.121 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.121 0.007 CID_6453821 | CID_6453821 | |
| 0.065 | 0.028 | 0.065 | CC chemokine 2 receptor antagonist | |||
| 0.066 | 0.029 | 0.066 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.042 CID_6453821 | ||
| 0.056 | 0.018 | 0.056 | Purinergic P2X4 antagonist | 0.049 0.026 CID_6453821 | ||
| 0.08 | 0.043 | 0.12 | Histidine decarboxylase inhibitor | 0.12 0.025 CID_6453821 | CID_6453821 | |
| 0.066 | 0.029 | 0.066 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.035 CID_6453821 | ||
| 0.21 | 0.173 | 0.21 | Vasodilator, coronary | |||
| 0.08 | 0.043 | 0.08 | Adenosine A3 receptor antagonist | |||
| 0.051 | 0.015 | 0.051 | Glycine transporter 1 inhibitor | |||
| 0.091 | 0.055 | 0.091 | Calcium antagonist | |||
| 0.087 | 0.052 | 0.087 | mTOR complex 2 inhibitor | |||
| 0.066 | 0.031 | 0.088 | Alcohol oxidase inhibitor | 0.088 0.021 CID_6453821 | CID_6453821 | |
| 0.051 | 0.016 | 0.051 | Substance P antagonist | |||
| 0.061 | 0.026 | 0.061 | Thromboxane synthase inhibitor | |||
| 0.069 | 0.033 | 0.069 | Cyclin B1 inhibitor | |||
| 0.067 | 0.032 | 0.067 | EphB4 antagonist | 0.063 0.035 CID_6453821 | ||
| 0.04 | 0.006 | 0.04 | Integrin alpha2beta1 antagonist | 0.025 0.022 CID_6453821 | ||
| 0.073 | 0.038 | 0.073 | Glutamate (mGluR7) antagonist | |||
| 0.052 | 0.018 | 0.052 | Thymidine kinase inhibitor | 0.047 0.021 CID_6453821 | ||
| 0.052 | 0.018 | 0.052 | Dipeptidyl peptidase IV inhibitor | |||
| 0.113 | 0.079 | 0.113 | MAO inhibitor | 0.108 0.082 CID_6453821 | ||
| 0.069 | 0.035 | 0.082 | Aromatase inhibitor | 0.082 0.027 CID_6453821 | CID_6453821 | |
| 0.056 | 0.023 | 0.056 | Neurokinin 3 antagonist | |||
| 0.061 | 0.028 | 0.061 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.041 CID_6453821 | ||
| 0.085 | 0.052 | 0.085 | Platelet growth factor antagonist | |||
| 0.048 | 0.015 | 0.048 | Cathepsin F inhibitor | |||
| 0.035 | 0.003 | 0.035 | Corticotropin releasing factor antagonist | 0.01 0.005 CID_6453821 | ||
| 0.041 | 0.008 | 0.047 | Sodium/glucose cotransporter 2 inhibitor | 0.047 0.007 CID_6453821 | CID_6453821 | |
| 0.048 | 0.016 | 0.048 | Farnesoid X receptor agonist | 0.043 0.02 CID_6453821 | ||
| 0.059 | 0.027 | 0.059 | Dipeptidyl peptidase inhibitor | |||
| 0.059 | 0.027 | 0.059 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.037 | 0.005 | 0.037 | Complement factor 1r inhibitor | |||
| 0.084 | 0.053 | 0.105 | Estrogen-related receptor beta agonist | 0.105 0.019 CID_6453821 | CID_6453821 | |
| 0.047 | 0.016 | 0.094 | Nicotinic acid receptor agonist | 0.094 0.005 CID_6453821 | CID_6453821 | |
| 0.047 | 0.017 | 0.047 | Kainate receptor agonist | 0.04 0.032 CID_6453821 | ||
| 0.055 | 0.024 | 0.055 | Histamine H4 receptor antagonist | |||
| 0.05 | 0.02 | 0.05 | Glutamate (mGluR4) antagonist | |||
| 0.109 | 0.079 | 0.109 | Beta amyloid protein antagonist | |||
| 0.068 | 0.038 | 0.068 | Beta 3 adrenoreceptor antagonist | 0.062 0.051 CID_6453821 | ||
| 0.052 | 0.022 | 0.052 | Glutamate (mGluR group III) agonist | 0.047 0.026 CID_6453821 | ||
| 0.037 | 0.008 | 0.037 | Purinergic P2Y15 antagonist | 0.029 0.019 CID_6453821 | ||
| 0.053 | 0.024 | 0.058 | Thymidylate synthase inhibitor | 0.058 0.018 CID_6453821 | CID_6453821 | |
| 0.202 | 0.173 | 0.202 | Vasodilator, peripheral | 0.191 0.187 CID_6453821 | ||
| 0.049 | 0.02 | 0.049 | Liver X receptor alpha agonist | 0.038 0.033 CID_6453821 | ||
| 0.053 | 0.025 | 0.053 | Cholesterol esterase inhibitor | |||
| 0.041 | 0.013 | 0.041 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.076 | 0.048 | 0.091 | Glutamate decarboxylase inhibitor | 0.091 0.035 CID_6453821 | CID_6453821 | |
| 0.033 | 0.005 | 0.033 | Dipeptidyl peptidase VIII inhibitor | |||
| 0.042 | 0.014 | 0.042 | AMPA 1 receptor antagonist | |||
| 0.035 | 0.007 | 0.035 | Geranylgeranyltransferase inhibitor | |||
| 0.086 | 0.059 | 0.086 | Granulocyte macrophage colony stimulating factor agonist | 0.083 0.066 CID_6453821 | ||
| 0.105 | 0.078 | 0.105 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.035 | 0.008 | 0.035 | Thymidine phosphorylase inhibitor | 0.025 0.02 CID_6453821 | ||
| 0.037 | 0.01 | 0.046 | CC chemokine 1 receptor antagonist | 0.046 0.007 CID_6453821 | CID_6453821 | |
| 0.043 | 0.016 | 0.043 | Sirtuin 2 inhibitor | |||
| 0.046 | 0.019 | 0.046 | TRPM8 blocker | |||
| 0.032 | 0.006 | 0.032 | Complement factor 1s inhibitor | |||
| 0.043 | 0.017 | 0.043 | Delayed rectifier potassium channel blocker | |||
| 0.03 | 0.004 | 0.03 | CC chemokine 9 receptor antagonist | 0.018 0.011 CID_6453821 | ||
| 0.118 | 0.092 | 0.139 | Vanilloid 1 agonist | 0.139 0.052 CID_6453821 | CID_6453821 | |
| 0.071 | 0.046 | 0.071 | I kappa B kinase 1 inhibitor | 0.065 0.055 CID_6453821 | ||
| 0.054 | 0.028 | 0.054 | Squalene epoxidase inhibitor | |||
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.007 CID_6453821 | ||
| 0.059 | 0.034 | 0.059 | Cyclin B2 inhibitor | |||
| 0.054 | 0.029 | 0.054 | Neurokinin antagonist | |||
| 0.058 | 0.033 | 0.058 | Aldose reductase inhibitor | 0.057 0.034 CID_6453821 | ||
| 0.096 | 0.072 | 0.132 | Folate antagonist | 0.132 0.03 CID_6453821 | CID_6453821 | |
| 0.053 | 0.029 | 0.053 | Bombesin 2 receptor antagonist | |||
| 0.049 | 0.025 | 0.049 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.042 | 0.018 | 0.063 | Phosphoglycerate kinase inhibitor | 0.063 0.011 CID_6453821 | CID_6453821 | |
| 0.033 | 0.009 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.014 CID_6453821 | ||
| 0.073 | 0.05 | 0.073 | Aminopeptidase I inhibitor | 0.066 0.059 CID_6453821 | ||
| 0.069 | 0.045 | 0.069 | Acetylcholine M5 receptor agonist | |||
| 0.06 | 0.037 | 0.06 | Calcium channel T-type blocker | |||
| 0.057 | 0.034 | 0.057 | Epithelial sodium channel blocker | 0.05 0.049 CID_6453821 | ||
| 0.032 | 0.01 | 0.032 | Hedgehog signaling activator | 0.029 0.016 CID_6453821 | ||
| 0.047 | 0.025 | 0.047 | Glutamate (mGluR group III) antagonist | |||
| 0.038 | 0.017 | 0.038 | Calcium release-activated channel blocker | |||
| 0.031 | 0.01 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 CID_6453821 | CID_6453821 | |
| 0.083 | 0.062 | 0.083 | Myeloperoxidase inhibitor | 0.078 0.07 CID_6453821 | ||
| 0.029 | 0.008 | 0.029 | Imidazoline I1 receptor antagonist | |||
| 0.081 | 0.061 | 0.081 | CC chemokine 5 receptor agonist | |||
| 0.041 | 0.021 | 0.042 | Glutamate (mGluR8) agonist | 0.042 0.019 CID_6453821 | CID_6453821 | |
| 0.033 | 0.013 | 0.033 | MAP3K8 inhibitor | |||
| 0.071 | 0.052 | 0.071 | Cathepsin G inhibitor | |||
| 0.025 | 0.005 | 0.03 | Nicotinic acid receptor 1 antagonist | 0.03 0.004 CID_6453821 | CID_6453821 | |
| 0.028 | 0.008 | 0.028 | ICAM 1 antagonist | |||
| 0.036 | 0.016 | 0.036 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.024 | 0.005 | 0.024 | Complement factor D inhibitor | |||
| 0.024 | 0.004 | 0.024 | Integrin beta2 antagonist | |||
| 0.025 | 0.006 | 0.025 | Alpha 2a adrenoreceptor agonist | |||
| 0.035 | 0.016 | 0.043 | Liver X receptor beta antagonist | 0.043 0.011 CID_6453821 | CID_6453821 | |
| 0.057 | 0.039 | 0.057 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.056 | 0.037 | 0.056 | Cyclin B inhibitor | |||
| 0.036 | 0.017 | 0.036 | CXC chemokine 3 receptor antagonist | |||
| 0.023 | 0.004 | 0.023 | Thromboxane A2 agonist | 0.015 0.012 CID_6453821 | ||
| 0.04 | 0.022 | 0.04 | Growth hormone secretagogue receptor antagonist | |||
| 0.038 | 0.02 | 0.038 | Fumarate hydratase inhibitor | 0.035 0.023 CID_6453821 | ||
| 0.166 | 0.148 | 0.166 | Spasmolytic | |||
| 0.051 | 0.033 | 0.051 | Potassium channel (Inward rectifier) blocker | |||
| 0.042 | 0.025 | 0.042 | Acid-sensing ion channel blocker | |||
| 0.054 | 0.037 | 0.054 | Thromboxane antagonist | |||
| 0.04 | 0.023 | 0.04 | Diamine oxidase inhibitor | |||
| 0.037 | 0.021 | 0.042 | RNA-directed RNA polymerase inhibitor | 0.042 0.017 CID_6453821 | CID_6453821 | |
| 0.059 | 0.042 | 0.059 | Dopamine D4 antagonist | |||
| 0.036 | 0.02 | 0.036 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.093 | 0.077 | 0.093 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.039 | 0.023 | 0.039 | Bradykinin antagonist | |||
| 0.034 | 0.018 | 0.034 | Cholesterol ester transfer protein antagonist | |||
| 0.023 | 0.008 | 0.023 | G-protein-coupled receptor 120 agonist | 0.017 0.012 CID_6453821 | ||
| 0.071 | 0.056 | 0.071 | Acetylcholine M4 receptor antagonist | |||
| 0.019 | 0.004 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.011 CID_6453821 | ||
| 0.019 | 0.005 | 0.019 | Integrin alphaLbeta2 antagonist | |||
| 0.035 | 0.021 | 0.035 | Carnitine palmitoyltransferase inhibitor | |||
| 0.034 | 0.02 | 0.034 | Dipeptidyl peptidase II inhibitor | |||
| 0.028 | 0.015 | 0.028 | Prostaglandin H2 antagonist | |||
| 0.062 | 0.048 | 0.062 | Transcription factor RelA inhibitor | |||
| 0.076 | 0.062 | 0.076 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.074 | 0.06 | 0.139 | Macrophage migration inhibitory factor inhibitor | 0.139 0.019 CID_6453821 | CID_6453821 | |
| 0.032 | 0.019 | 0.032 | AMPA 3 receptor antagonist | |||
| 0.057 | 0.045 | 0.057 | Sphingosine kinase inhibitor | |||
| 0.025 | 0.013 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.065 | 0.053 | 0.065 | Carbonic anhydrase VA inhibitor | |||
| 0.053 | 0.041 | 0.053 | Carbonic anhydrase VB inhibitor | |||
| 0.116 | 0.104 | 0.116 | Cytidine deaminase inhibitor | |||
| 0.035 | 0.024 | 0.035 | Retinoid X alpha receptor agonist | 0.035 0.024 CID_6453821 | ||
| 0.031 | 0.019 | 0.031 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.109 | 0.098 | 0.109 | DNA repair enzyme inhibitor | |||
| 0.046 | 0.035 | 0.046 | Aldosterone antagonist | |||
| 0.033 | 0.021 | 0.062 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.062 0.008 CID_6453821 | CID_6453821 | |
| 0.053 | 0.042 | 0.053 | Glucosylceramidase inhibitor | |||
| 0.129 | 0.117 | 0.146 | Melanin inhibitor | 0.146 0.088 CID_6453821 | CID_6453821 | |
| 0.021 | 0.01 | 0.021 | Cyclin T1 inhibitor | |||
| 0.078 | 0.067 | 0.078 | Ca(v)3.1 blocker | |||
| 0.016 | 0.005 | 0.016 | Carbonic anhydrase XI inhibitor | |||
| 0.015 | 0.004 | 0.015 | Progesterone receptor A antagonist | |||
| 0.031 | 0.021 | 0.031 | Prostaglandin agonist | 0.031 0.021 CID_6453821 | ||
| 0.046 | 0.036 | 0.046 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.037 | 0.026 | 0.037 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.041 | 0.031 | 0.041 | Secretase gamma inhibitor | |||
| 0.134 | 0.124 | 0.158 | DNA methyltransferase I inhibitor | 0.158 0.096 CID_6453821 | CID_6453821 | |
| 0.023 | 0.014 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.025 0.012 CID_6453821 | CID_6453821 | |
| 0.05 | 0.041 | 0.05 | Toll-Like receptor 8 antagonist | |||
| 0.024 | 0.015 | 0.024 | Prostaglandin E2 agonist | 0.023 0.017 CID_6453821 | ||
| 0.112 | 0.104 | 0.112 | CDC-like kinase 1 inhibitor | |||
| 0.065 | 0.057 | 0.065 | Protein kinase C beta inhibitor | |||
| 0.013 | 0.005 | 0.013 | Thromboxane agonist | 0.011 0.007 CID_6453821 | ||
| 0.028 | 0.021 | 0.028 | Vasopressin 1A agonist | |||
| 0.02 | 0.013 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.054 | 0.047 | 0.058 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.058 0.042 CID_6453821 | CID_6453821 | |
| 0.054 | 0.047 | 0.054 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.021 | 0.014 | 0.021 | Kainate receptor 5 antagonist | |||
| 0.046 | 0.039 | 0.046 | Thromboxane A2 antagonist | |||
| 0.086 | 0.08 | 0.086 | Alpha 2c adrenoreceptor antagonist | |||
| 0.041 | 0.035 | 0.067 | Sphingosine 1-phosphate receptor agonist | 0.067 0.013 CID_6453821 | CID_6453821 | |
| 0.056 | 0.05 | 0.056 | Cyclin D1 inhibitor | |||
| 0.117 | 0.111 | 0.165 | Farnesoid X receptor antagonist | 0.165 0.039 CID_6453821 | CID_6453821 | |
| 0.061 | 0.055 | 0.061 | CDC7 inhibitor | |||
| 0.026 | 0.021 | 0.026 | Bradykinin B1 receptor antagonist | |||
| 0.032 | 0.027 | 0.032 | Glutamate (mGluR4) agonist | |||
| 0.031 | 0.026 | 0.034 | Liver X receptor beta agonist | 0.034 0.022 CID_6453821 | CID_6453821 | |
| 0.068 | 0.062 | 0.068 | Na+ K+ transporting ATPase inhibitor | 0.066 0.063 CID_6453821 | ||
| 0.021 | 0.016 | 0.021 | Aggrecanase 2 inhibitor | |||
| 0.026 | 0.021 | 0.026 | Myristoyl transferase inhibitor | |||
| 0.055 | 0.05 | 0.055 | Alpha 2 adrenoreceptor agonist | |||
| 0.034 | 0.029 | 0.034 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.029 | 0.025 | 0.032 | HCV NS5B polymerase inhibitor | 0.032 0.021 CID_6453821 | CID_6453821 | |
| 0.099 | 0.094 | 0.099 | Caspase 3 inhibitor | |||
| 0.067 | 0.062 | 0.073 | Peroxisome proliferator-activated receptor gamma antagonist | 0.073 0.047 CID_6453821 | CID_6453821 | |
| 0.076 | 0.071 | 0.076 | Caspase 7 inhibitor | |||
| 0.152 | 0.148 | 0.152 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.037 | 0.033 | 0.037 | CC chemokine 3 receptor antagonist | |||
| 0.023 | 0.019 | 0.023 | Kainate receptor 4 antagonist | |||
| 0.007 | 0.004 | 0.007 | DNA polymerase III subunit alpha inhibitor | |||
| 0.047 | 0.044 | 0.047 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.045 | 0.042 | 0.045 | Carbonic anhydrase XII inhibitor | |||
| 0.063 | 0.061 | 0.063 | CXC chemokine receptor antagonist | |||
| 0.032 | 0.029 | 0.032 | Arginase inhibitor | |||
| 0.032 | 0.03 | 0.032 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.065 | 0.063 | 0.065 | Carbonic anhydrase XIII inhibitor | |||
| 0.018 | 0.015 | 0.018 | Prostaglandin EP1 antagonist | |||
| 0.025 | 0.022 | 0.025 | Nicotinic acid receptor 2 antagonist | |||
| 0.02 | 0.018 | 0.02 | Glutamate (mGluR1a) agonist | |||
| 0.05 | 0.047 | 0.05 | Argininosuccinate synthase inhibitor | |||
| 0.02 | 0.018 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.03 | 0.028 | 0.03 | GHS receptor antagonist | |||
| 0.03 | 0.028 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.018 | 0.016 | 0.018 | Alpha 2b adrenoreceptor agonist | |||
| 0.085 | 0.083 | 0.085 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.058 | 0.056 | 0.076 | Carbonic anhydrase V inhibitor | 0.076 0.038 CID_6453821 | CID_6453821 | |
| 0.048 | 0.046 | 0.048 | Autotaxin inhibitor | |||
| 0.021 | 0.019 | 0.021 | Prostaglandin F2 alpha agonist | 0.021 0.018 CID_6453821 | ||
| 0.041 | 0.04 | 0.041 | Carbonic anhydrase VII inhibitor | 0.041 0.04 CID_6453821 | ||
| 0.033 | 0.032 | 0.033 | Melanocortin 1 antagonist | |||
| 0.075 | 0.074 | 0.075 | Alpha 2 adrenoreceptor antagonist | |||
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.031 | 0.03 | 0.031 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.023 | 0.025 | 0.024 | Vanilloid 2 agonist | 0.024 0.022 CID_6453821 | CID_6453821 | |
| 0.064 | 0.069 | 0.077 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.077 0.054 CID_6453821 | CID_6453821 | |
| 0.119 | 0.124 | 0.132 | CC chemokine 6 receptor antagonist | 0.132 0.064 CID_6453821 | CID_6453821 | |
| 0.035 | 0.041 | 0.059 | Sphingosine 1-phosphate receptor 1 agonist | 0.059 0.013 CID_6453821 | CID_6453821 | |
| 0.034 | 0.04 | 0.037 | CDK5/p25 inhibitor | 0.037 0.033 CID_6453821 | CID_6453821 | |
| 0.17 | 0.177 | 0.188 | Lipoxygenase inhibitor | 0.188 0.153 CID_6453821 | CID_6453821 | |
| 0.07 | 0.08 | 0.075 | MAP kinase kinase 7 inhibitor | 0.075 0.062 CID_6453821 | CID_6453821 | |
| 0.056 | 0.067 | 0.067 | Dopamine antagonist | 0.067 0.057 CID_6453821 | CID_6453821 | |
| 0.027 | 0.04 | 0.033 | Glutamate (mGluR3) agonist | 0.033 0.02 CID_6453821 | CID_6453821 | |
| 0.02 | 0.034 | 0.198 | Estrogen receptor alpha agonist | 0.198 0.005 CID_6453821 | CID_6453821 | |
| 0.111 | 0.126 | 0.179 | Protein-tyrosine phosphatase inhibitor | 0.179 0.057 CID_6453821 | CID_6453821 | |
| 0.029 | 0.046 | 0.092 | Estradiol 17 beta-dehydrogenase inhibitor | 0.092 0.011 CID_6453821 | CID_6453821 | |
| 0.124 | 0.143 | 0.135 | Pyruvate kinase inhibitor | 0.135 0.13 CID_6453821 | CID_6453821 | |
| 0.003 | 0.024 | 0.008 | Insulin like growth factor 3 antagonist | 0.008 0.004 CID_6453821 | CID_6453821 | |
| 0.019 | 0.042 | 0.034 | Thyroid hormone agonist | 0.034 0.009 CID_6453821 | CID_6453821 | |
| 0.026 | 0.052 | 0.053 | Urate transporter 1 inhibitor | 0.053 0.017 CID_6453821 | CID_6453821 | |
| 0.085 | 0.112 | 0.12 | M18 aspartyl aminopeptidase inhibitor | 0.12 0.071 CID_6453821 | CID_6453821 | |
| 0.004 | 0.031 | 0.008 | Thyroid hormone beta agonist | 0.008 0.007 CID_6453821 | CID_6453821 | |
| 0.011 | 0.041 | 0.047 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.047 0.007 CID_6453821 | CID_6453821 | |
| 0.047 | 0.078 | 0.066 | Prostaglandin F2 alpha antagonist | 0.066 0.037 CID_6453821 | CID_6453821 | |
| 0.121 | 0.151 | 0.135 | DNA methylase inhibitor | 0.135 0.132 CID_6453821 | CID_6453821 | |
| 0.045 | 0.083 | 0.067 | Adenine nucleotide translocase inhibitor | 0.067 0.018 CID_6453821 | CID_6453821 | |
| 0.052 | 0.097 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.04 CID_6453821 | CID_6453821 | |
| 0.023 | 0.068 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.018 CID_6453821 | CID_6453821 | |
| 0.017 | 0.065 | 0.027 | Liver X receptor alpha antagonist | 0.027 0.025 CID_6453821 | CID_6453821 | |
| 0.058 | 0.107 | 0.076 | Opioid kappa receptor antagonist | 0.076 0.065 CID_6453821 | CID_6453821 | |
| 0.018 | 0.075 | 0.068 | Dopamine D5 antagonist | 0.068 0.015 CID_6453821 | CID_6453821 | |
| 0.007 | 0.073 | 0.195 | Estrogen receptor beta agonist | 0.195 0.005 CID_6453821 | CID_6453821 | |
| 0.011 | 0.099 | 0.144 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.144 0.004 CID_6453821 | CID_6453821 | |
| 0.09 | 0.181 | 0.182 | Dual specificity phosphatase 3 inhibitor | 0.182 0.072 CID_6453821 | CID_6453821 | |
| 0.024 | 0.12 | 0.053 | Raf kinase C inhibitor | 0.053 0.049 CID_6453821 | CID_6453821 | |
| 0.01 | 0.141 | 0.174 | Estrogen agonist | 0.174 0.009 CID_6453821 | CID_6453821 | |
| 0.082 | 0.234 | 0.159 | Dual specificity phosphatase inhibitor | 0.159 0.084 CID_6453821 | CID_6453821 | |
| 0.027 | 0.271 | 0.069 | HIV-1 integrase inhibitor | 0.069 0.049 CID_6453821 | CID_6453821 | |
| 0.008 | 0.253 | 0.039 | Nicotinic acid receptor 2 agonist | 0.039 0.021 CID_6453821 | CID_6453821 | |
| 0.097 | 0.343 | 0.247 | Immunosuppressant | 0.247 0.15 CID_6453821 | CID_6453821 | |
| 0.004 | 0.26 | 0.018 | Thyroid hormone alpha antagonist | 0.018 0.009 CID_6453821 | CID_6453821 | |
| 0.004 | 0.314 | 0.024 | Thyroid hormone alpha agonist | 0.024 0.005 CID_6453821 | CID_6453821 | |
| 0.037 | 0.379 | 0.086 | Vanilloid agonist | 0.086 0.054 CID_6453821 | CID_6453821 | |
| 0.006 | 0.363 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.02 CID_6453821 | CID_6453821 | |
| 0.02 | 0.785 | 0.116 | Interleukin 4 antagonist | 0.116 0.091 CID_6453821 | CID_6453821 | |
| 0.003 | 0.787 | 0.054 | Sphingosine 1-phosphate receptor 3 agonist | 0.054 0.014 CID_6453821 | CID_6453821 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |